The shares of the company, which has a market cap of Rs 410 crore, have a 52-week high of Rs 42.44 and a 52-week low of Rs 8.37.
Shares of Remedium Lifecare hit 5 per cent upper circuit on Thursday amid firm buying in the stock as market as benchmark equity indices Sensex and Nifty advanced in early trade. The counter opened at Rs 10.07 and gained further to touch the high of Rs 10.19. This is a high of 4.94 per cent from the previous close of Rs 9.71 per cent.
The shares of the company, which has a market cap of Rs 410 crore, have a 52-week high of Rs 42.44 and a 52-week low of Rs 8.37. The stock has outperformed the sector by 3.74 per cent and has been gaining for the last 3 days and has risen 15.66 per cent.
Meanwhile, the company has approved an increase in authorised share capital from Rs 42 crore to Rs 60 crore divided into 60,00,00,000 equity shares of Re 1 each. “The Authorized Share Capital of the Company is Rs. 60,00,00,000/- (Rupees Sixty Crores Only) divided into 60,00,00,000 (Sixty Crores only) Equity Shares of Re. 1/- (Rupee One only) each,” the company said in an exchange filing.
Earlier, the company said that it would take up a proposal for the acquisition of an unlisted company in the speciality chemicals sector with a global footprint. The company said that its board will meet in the first week of August.
(Disclaimer: The information provided in this article is for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.)
